• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学肿瘤分级对淋巴结阴性乳腺癌患者的预后影响。

The prognostic effect of histological tumor grade in node-negative breast cancer patients.

作者信息

Schumacher M, Schmoor C, Sauerbrei W, Schauer A, Ummenhofer L, Gatzemeier W, Rauschecker H

机构信息

Institute of Medical Biometry and Informatics, University of Freiburg, Germany.

出版信息

Breast Cancer Res Treat. 1993;25(3):235-45. doi: 10.1007/BF00689838.

DOI:10.1007/BF00689838
PMID:8369525
Abstract

The prognostic effect of histological tumor grade was evaluated in 1036 patients with early breast cancer (pT1 pN0 M0) entered into a trial comparing mastectomy and breast preserving treatment. All analyses were adjusted for the factors treatment, patients' age, and tumor size. Tumor grade was defined according to Bloom and Richardson based on the sum of scores assigned to each of three histological features: 1) degree of differentiation, 2) pleomorphism, and 3) mitotic index. The relative importance of these factors with regard to disease-free survival was evaluated. In univariate as well as in multivariate analyses the pleomorphism was the only factor showing a significant effect (univariate: p = 0.0024, multivariate: p = 0.015). It was investigated how the factors should be combined to define a histological grading score which yields the best possible classification of the patients with respect to prognosis. A new grading system was defined splitting the patients into three groups: 1) pleomorphism 1; 2) pleomorphism 2 or pleomorphism 3 and mitotic index 1; 3) pleomorphism 3 and mitotic index 2 or 3. This yields a good classification of the patients with respect to prognosis (p = 0.0004). The prognostic effect of this score was compared with the effects of the grading systems proposed in the literature. According to Bloom and Richardson and in the modified version by Schauer and Weiss, grading is based on the sum of scores of the various histological factors. Therefore, the strong effect of the pleomorphism was diluted in these grading definitions (Bloom and Richardson: p = 0.03, Schauer and Weiss: p = 0.028). The grading system proposed by Le Doussal et al. consists only of the scores of pleomorphism and mitotic index (p = 0.014). In summary, the factor pleomorphism showed a stronger effect on disease-free survival by itself than the grading systems proposed in the literature.

摘要

在一项比较乳房切除术和保乳治疗的试验中,对1036例早期乳腺癌(pT1 pN0 M0)患者评估了组织学肿瘤分级的预后影响。所有分析均针对治疗、患者年龄和肿瘤大小等因素进行了调整。肿瘤分级根据Bloom和Richardson方法定义,基于对三个组织学特征分别赋予的分数总和:1)分化程度;2)多形性;3)有丝分裂指数。评估了这些因素对无病生存期的相对重要性。在单变量和多变量分析中,多形性是唯一显示出显著影响的因素(单变量:p = 0.0024,多变量:p = 0.015)。研究了如何组合这些因素以定义一个组织学分级分数,从而在预后方面对患者进行尽可能最佳的分类。定义了一种新的分级系统,将患者分为三组:1)多形性1级;2)多形性2级或多形性3级且有丝分裂指数1级;3)多形性3级且有丝分裂指数2级或3级。这在预后方面对患者进行了良好的分类(p = 0.0004)。将该分数的预后影响与文献中提出的分级系统的影响进行了比较。根据Bloom和Richardson以及Schauer和Weiss的修改版本,分级基于各种组织学因素的分数总和。因此,在这些分级定义中,多形性的强烈影响被稀释了(Bloom和Richardson:p = 0.03,Schauer和Weiss:p = 0.028)。Le Doussal等人提出的分级系统仅由多形性和有丝分裂指数的分数组成(p = 0.014)。总之,多形性因素本身对无病生存期的影响比文献中提出的分级系统更强。

相似文献

1
The prognostic effect of histological tumor grade in node-negative breast cancer patients.组织学肿瘤分级对淋巴结阴性乳腺癌患者的预后影响。
Breast Cancer Res Treat. 1993;25(3):235-45. doi: 10.1007/BF00689838.
2
Breast preservation versus mastectomy in early breast cancer--1991 update of the GBSG 1--protocol and prognostic factors. The German Breast Cancer Study Group.早期乳腺癌保乳术与乳房切除术——GBSG 1的1991年更新——方案及预后因素。德国乳腺癌研究组
Strahlenther Onkol. 1992 Apr;168(4):191-202.
3
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index.采用布卢姆-理查森系统对乳腺癌进行恶性程度分级与增殖指数:分级的可重复性及增殖指数的优势
Mod Pathol. 2005 Aug;18(8):1067-78. doi: 10.1038/modpathol.3800388.
4
Role of mitotic counts in the grading and prognosis of the breast cancer.有丝分裂计数在乳腺癌分级及预后中的作用。
Indian J Pathol Microbiol. 2002 Jul;45(3):247-54.
5
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.乳腺癌的病理预后因素。I. 乳腺癌组织学分级的价值:一项长期随访大型研究的经验
Histopathology. 1991 Nov;19(5):403-10. doi: 10.1111/j.1365-2559.1991.tb00229.x.
6
Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas.斯卡夫-布鲁姆-理查森(SBR)组织学分级核成分的预后价值。基于对1262例浸润性导管癌的多变量分析的改良评分。
Cancer. 1989 Nov 1;64(9):1914-21. doi: 10.1002/1097-0142(19891101)64:9<1914::aid-cncr2820640926>3.0.co;2-g.
7
Comparison of the prognostic significance of current and modified histological grades in breast carcinomas.乳腺癌当前组织学分级与改良组织学分级的预后意义比较。
Anticancer Res. 1995 Nov-Dec;15(6B):2611-7.
8
Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.825例乳腺癌患者中Scarff-Bloom-Richardson组织学分级与诺丁汉组织学分级预后价值的比较:有丝分裂计数作为两种分级系统组成部分的重要意义。
Anticancer Res. 1998 Jan-Feb;18(1B):571-6.
9
Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.DNA细胞计量术在281例绝经前淋巴结阴性乳腺癌患者中的预后价值:一项对照试验中的多因素分析,纳入Ki-67指数、有丝分裂计数和微血管密度
Cancer. 2000 Oct 15;89(8):1748-57. doi: 10.1002/1097-0142(20001015)89:8<1748::aid-cncr15>3.0.co;2-e.
10
Therapy of small breast cancer: a prospective study on 1036 patients with special emphasis on prognostic factors.小乳腺癌的治疗:一项针对1036例患者的前瞻性研究,特别关注预后因素。
Int J Radiat Oncol Biol Phys. 1992;23(5):907-14. doi: 10.1016/0360-3016(92)90894-n.

引用本文的文献

1
Amplification of Genomic DNA for Decoy Receptor 3 Predicts Post-Resection Disease Recurrence in Breast Cancer Patients.诱饵受体3基因组DNA的扩增可预测乳腺癌患者术后疾病复发。
World J Oncol. 2014 Feb;5(1):14-23. doi: 10.14740/wjon764w. Epub 2014 Mar 11.
2
Molecular expression of vascular endothelial growth factor, prokineticin receptor-1 and other biomarkers in infiltrating canalicular carcinoma of the breast.血管内皮生长因子、促动力素受体-1及其他生物标志物在乳腺浸润性小管癌中的分子表达
Oncol Lett. 2016 Oct;12(4):2720-2727. doi: 10.3892/ol.2016.4961. Epub 2016 Aug 5.
3
The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics.

本文引用的文献

1
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
2
Tree-structured survival analysis.树状结构生存分析
Cancer Treat Rep. 1985 Oct;69(10):1065-9.
3
Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis.肿瘤分级在伴有腋窝淋巴结转移的乳腺癌辅助治疗临床试验中的预后意义。
代谢紊乱治疗与乳腺癌特征之间的关联。
Int J Endocrinol. 2016;2016:4658469. doi: 10.1155/2016/4658469. Epub 2016 Aug 28.
4
Analysis of the potent prognostic factors in luminal-type breast cancer.分析腔面型乳腺癌的有效预后因素。
J Breast Cancer. 2012 Dec;15(4):401-6. doi: 10.4048/jbc.2012.15.4.401. Epub 2012 Dec 31.
5
Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise.白细胞介素-1基因多态性与人体肌肉对急性抗阻运动的炎症反应相关。
J Physiol. 2004 Nov 1;560(Pt 3):617-26. doi: 10.1113/jphysiol.2004.067876. Epub 2004 Aug 26.
6
Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma.诺丁汉组织学分级及其组成部分在早期(pT1N0M0)乳腺癌中的长期预后价值。
J Clin Pathol. 2002 Feb;55(2):88-92. doi: 10.1136/jcp.55.2.88.
7
Morphometric grading of breast cancer: thresholds for tubular differentiation.乳腺癌的形态计量学分级:管状分化的阈值
Br J Cancer. 2000 May;82(10):1656-61. doi: 10.1054/bjoc.2000.1222.
8
Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG).模拟标准预后因素对淋巴结阳性乳腺癌的影响。德国乳腺癌研究组(GBSG)。
Br J Cancer. 1999 Apr;79(11-12):1752-60. doi: 10.1038/sj.bjc.6690279.
9
Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.与传统组织病理学因素相比,增殖细胞核抗原和c-erbB-2在乳腺癌中的预后价值。
J Cancer Res Clin Oncol. 1995;121(2):115-22. doi: 10.1007/BF01202223.
10
Therapy of small breast cancer--four-year results of a prospective non-randomized study. German Breast Cancer Study Group (GBSG).小乳腺癌的治疗——一项前瞻性非随机研究的四年结果。德国乳腺癌研究组(GBSG)
Breast Cancer Res Treat. 1995 Apr;34(1):1-13. doi: 10.1007/BF00666486.
Cancer. 1986 Dec 15;58(12):2662-70. doi: 10.1002/1097-0142(19861215)58:12<2662::aid-cncr2820581219>3.0.co;2-y.
4
Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer.肿瘤核分级、雌激素受体和孕激素受体:它们单独或联合作为乳腺癌辅助治疗后预后指标的价值。
Breast Cancer Res Treat. 1986;7(3):147-60. doi: 10.1007/BF01806245.
5
Quality control requirements in estrogen receptor determination.雌激素受体测定中的质量控制要求。
Cancer Res. 1986 Aug;46(8 Suppl):4249s-4250s.
6
Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial.浸润性导管癌的组织学恶性分级。一项来自多中心试验的低风险癌预后因素的回归分析。
Cancer. 1987 Sep 15;60(6):1299-305. doi: 10.1002/1097-0142(19870915)60:6<1299::aid-cncr2820600623>3.0.co;2-l.
7
Adjuvant therapy of node-negative breast cancer.淋巴结阴性乳腺癌的辅助治疗。
N Engl J Med. 1989 Feb 23;320(8):525-7. doi: 10.1056/NEJM198902233200811.
8
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.高危淋巴结阴性乳腺癌辅助化疗的疗效。一项多组间研究。
N Engl J Med. 1989 Feb 23;320(8):485-90. doi: 10.1056/NEJM198902233200803.
9
Tumor grade as a prognostic factor in primary breast cancer.肿瘤分级作为原发性乳腺癌的一个预后因素。
Eur J Cancer Clin Oncol. 1989 Mar;25(3):403-9. doi: 10.1016/0277-5379(89)90251-4.
10
Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.一期围手术期辅助化疗后,淋巴结阴性乳腺癌患者的长期无病生存期。
N Engl J Med. 1989 Feb 23;320(8):491-6. doi: 10.1056/NEJM198902233200804.